242 related articles for article (PubMed ID: 35908630)
1. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
[TBL] [Abstract][Full Text] [Related]
2. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
[TBL] [Abstract][Full Text] [Related]
5. Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases.
Pandey P; Pande A; Mandal S; Marik A; Devra AK; Sinha VK; Bhatt AP; Gajway SY; Singh RK; Mishra S; Jha S
Transpl Immunol; 2023 Apr; 77():101783. PubMed ID: 36608831
[TBL] [Abstract][Full Text] [Related]
6. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
8. Significance of Luminex-crossmatch assay and its mean fluorescence intensity - a retrospective observation in 380 renal transplant cases.
Pandey P; Pande A; Mishra S; Setya D; Devra AK; Sinha VK; Bhatt AP
Pol Przegl Chir; 2022 Apr; 94(2):38-48. PubMed ID: 35485317
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
[TBL] [Abstract][Full Text] [Related]
11. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
[TBL] [Abstract][Full Text] [Related]
12. Virtual crossmatch in kidney transplantation.
Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
[TBL] [Abstract][Full Text] [Related]
13. The correlation of results of panel reactive antibody, identification, and single antigen beads in detection of anti-HLA antibodies: Istanbul Faculty of Medicine, tissue typing laboratory experience.
Ciftci HS; Oguz FS; Cinar CK; Izgi DK
Transpl Immunol; 2023 Oct; 80():101891. PubMed ID: 37433395
[TBL] [Abstract][Full Text] [Related]
14. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Pandey S; Harville TO
Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
[TBL] [Abstract][Full Text] [Related]
16. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
[TBL] [Abstract][Full Text] [Related]
17. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
18. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
Tafulo S; Osório E; Mendes C; Liwski R
Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
[TBL] [Abstract][Full Text] [Related]
19. Novel Flow Cytometry-Based Method for Detection of Anti-HLA Complement Activating Donor-Specific Antibodies in Renal Transplant Recipients and Its Comparison With Other Conventional Detection Methods.
Rani L; Singh H; Saikia B; Aggarwal R; Kumar Y; Kumar M; Chhabra S; Kumar M; Kumar B; Kumar V; Das P; Sharma A; Ramchandran R; Kohli HS; Minz RW
Transplant Proc; 2023; 55(1):134-139. PubMed ID: 36609023
[TBL] [Abstract][Full Text] [Related]
20. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation.
Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB
Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]